All three major indices are trading up today with the

Dow Jones Industrial Average

(

^DJI

) trading up 24 points (0.1%) at 17,741 as of Thursday, March 31, 2016, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,790 issues advancing vs. 1,130 declining with 157 unchanged.

The Health Care sector currently sits up 2.1% versus the S&P 500, which is up 0.1%. A company within the sector that fell today was

Sanofi

(

SNY

), up 0.7%. Top gainers within the sector include

Medivation

(

MDVN

), up 23.4%,

Alnylam Pharmaceuticals

(

ALNY

), up 8.9%,

ACADIA Pharmaceuticals

(

ACAD

), up 7.1%,

Biomarin Pharmaceutical

(

BMRN

), up 6.2% and

Alkermes

(

ALKS

), up 5.9%.

TheStreet would like to highlight 3 stocks pushing the sector lower today:

3.

Endo International

(

ENDP

) is one of the companies pushing the Health Care sector lower today. As of noon trading, Endo International is down $1.33 (-4.7%) to $27.12 on heavy volume. Thus far, 9.7 million shares of Endo International exchanged hands as compared to its average daily volume of 5.7 million shares. The stock has ranged in price between $25.98-$28.90 after having opened the day at $28.55 as compared to the previous trading day's close of $28.45.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Endo International plc develops, manufactures, and distributes pharmaceutical products and devices worldwide. Its U.S. Endo International has a market cap of $6.4 billion and is part of the drugs industry. Shares are down 53.5% year-to-date as of the close of trading on Wednesday. Currently there are 7 analysts that rate Endo International a buy, no analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates

Endo International

as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally high debt management risk, disappointing return on equity and generally disappointing historical performance in the stock itself. Get the full

Endo International Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

Humana

(

HUM

) is down $1.10 (-0.6%) to $183.79 on light volume. Thus far, 216,659 shares of Humana exchanged hands as compared to its average daily volume of 985,000 shares. The stock has ranged in price between $183.01-$185.75 after having opened the day at $185.75 as compared to the previous trading day's close of $184.89.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Humana Inc., together with its subsidiaries, operates as a health and well-being company. The company operates through three segments: Retail, Group, and Healthcare Services. Humana has a market cap of $27.5 billion and is part of the health services industry. Shares are up 3.6% year-to-date as of the close of trading on Wednesday. Currently there are 6 analysts that rate Humana a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates

Humana

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, notable return on equity and solid stock price performance. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Humana Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

Anthem

(

ANTM

) is down $1.20 (-0.9%) to $138.77 on light volume. Thus far, 483,309 shares of Anthem exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $137.65-$140.30 after having opened the day at $139.48 as compared to the previous trading day's close of $139.97.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial and Specialty Business, Government Business, and Other. Anthem has a market cap of $36.7 billion and is part of the health services industry. Shares are up 0.4% year-to-date as of the close of trading on Wednesday. Currently there are 9 analysts that rate Anthem a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates

Anthem

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Anthem Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health care sector could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health care sector could consider

ProShares Ultra Short Health Care

(

RXD

).